HomeTATACHEM › Filing
🔔 Get instant alerts when TATACHEM files quarterly results on BSE Start free trial →
Tata Chemicals Ltd (TATACHEM)

Investor Presentation for the quarter ended June 30, 2026

Filed: 27 Jul 2026, 18:33 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1FY27 consolidated revenue 4,255 Cr +14% y-y; EBITDA 555 Cr -14% y-y; PAT 60 Cr (continuing ops) - Net debt reduced to 5,692 Cr vs 5,961 Cr in Q4FY26 due to asset monetisation - Living Essentials segment revenue up 25% y-y; Industrial Essentials revenue up 13% y-y; Farm Essentials revenue up 7% y-y - Soda ash demand flat near-term; margin pressure from higher energy and freight costs - Expansion projects: 82.5 KTPA salt plant Gujarat, 50 KTPA silica plant Tamil Nadu, 40 KTPA bicarbonate Singapore - Sustainability focus: biomass boiler, renewable electricity, biodiversity projects ongoing - Standalone EBITDA improved YoY despite consolidated EBITDA decline from lower overseas realizations
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TATACHEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TATACHEM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Tata Chemicals Ltd

Important. The summary above is generated automatically from Tata Chemicals Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.